Latest Market Guidance News

TradeWindow reports solid growth in recurring revenue and average revenue per customer but lowers its FY26 trading revenue guidance due to softer transactional volumes in Q3.

Image Resources NL reported a strong finish to 2025 with record heavy mineral concentrate production and sales, alongside promising developments in its gold exploration and synthetic rutile innovation.

Alkane Resources delivered a robust December quarter with 43,663 ounces of gold equivalent production and a significant increase in cash and bullion holdings to A$246 million. The company maintains its FY2026 production guidance amid ongoing exploration and development.

Weebit Nano has raised its FY26 revenue guidance to a minimum of $10 million following the signing of multiple IP licensing agreements with semiconductor fabs and product companies.

APA Group has announced a modest 1.9% increase in its interim distribution to 27.5 cents per security for the half year ending December 2025, maintaining steady income growth for investors.

SPC Global Holdings delivered a transformational FY25 with robust financial results and strategic international growth, setting the stage for a confident 25% EBITDA increase in FY26.

EML Payments has affirmed its FY26 underlying EBITDA guidance of A$58-63 million following a solid Q1 trading update, underpinned by a growing new program pipeline and operational efficiencies.

Saunders International anticipates a weaker first half in FY26 amid ongoing operational challenges but gains momentum with major contracts and strategic expansion into New South Wales.

Image Resources has trimmed its heavy mineral concentrate sales guidance for 2025 by around 9%, citing weaker demand and logistical challenges, while extending repayment terms on prepayment facilities.

Credit Corp Group has reaffirmed its FY26 guidance, highlighting robust earnings growth driven by operational improvements across its US debt buying and Australian/New Zealand lending segments.

SPC Global Holdings Ltd has reported FY25 proforma results exceeding guidance with a normalised EBITDA of $30.3 million, setting the stage for ambitious growth and international expansion in FY26.

SomnoMed has delivered a standout FY25 with revenue and EBITDA exceeding market expectations, driven by strong regional growth and operational improvements. The company is now expanding capacity and advancing its innovative Rest Assure device.